Skip to main content
. 2014 Jun 19;2014:798742. doi: 10.1155/2014/798742

Figure 13.

Figure 13

Secondary structure changes during MD simulation. (a) Tetrahydropalmatine, (b) Reserpiline, (c) (+)-Corydaline, and (d) Dinaciclib.